Business Model and Product Portfolio
Eye Circulation Measurement
Image-Based Technologies (OCT)
- Type: Retinal Circulation
- Percentage of Ocular Blood Flow: 10%
- Characteristics: Anatomic and Static
- Coverage: Posterior Pole Circulation
- Price: ~$100K
- Disease Stage: Late
Color Doppler Imaging
- Type: Retrobulbar Circulation
- Percentage of Ocular Blood Flow: 50%
- Characteristics: Functional
- Coverage: Arterial Feeder Circulation
- Price: ~$100K per device
- Disease Stage: Early and Late
Choroidal Circulation Analyzer
- Type: Choroidal Circulation
- Percentage of Ocular Blood Flow: 85-90%
- Characteristics: Functional & Real-Time
- Coverage: Global & Perfusion Pressure
- Price: ~$10-15K per device
- Disease Stage: Early and Late
Key Benefits
- Unique Quantitative Measurement: The OculoPULSE-CCA is the only device capable of quantitatively assessing the primary components of eye circulation.
- Rapid, Noninvasive, and Cost-Effective: Provides critical insights without the need for intricate procedures.
- Early Disease Detection and Monitoring: The device effectively identifies early-stage diseases and allows for ongoing monitoring of disease progression.
- Facilitates Immediate Therapeutic Intervention: Clinicians can make timely decisions regarding treatment based on real-time data provided by the OculoPULSE-CCA.
- Potential Replacement for Standard IOP Technology: This innovative device has the capability to supplant existing gold-standard intraocular pressure (IOP) measurement technologies used worldwide.
- Reimbursement Code Available: A reimbursement code (0198T) has been established to streamline the billing process.
- Robust Validation: The technology is supported by validation in over 300 peer-reviewed publications, underscoring its reliability and credibility in the field.
With these advancements, the OculoPULSE Choroidal Circulation Analyzer is set to revolutionize the management of ocular health by providing comprehensive, real-time data for clinicians.